Back

Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.

11 May 2024 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 2 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speakers

Photo
Professor Angela Sciacqua

Magna Graecia University of Catanzaro, Catanzaro (Italy)

Photo
Doctor Giuseppe Armentaro

University Hospital Renato Dulbecco, Catanzaro (Italy)

6 More presentations in this session

Presentation thumbnail
Echocardiographic characteristics of patients with CpcPH, and IpcPH in HFpEF, insight of PHHF study
Doctor E. Berthelot (Le Kremlin-Bicetre, FR)
Abstract Slides Video
Presentation thumbnail
Traditional heart failure drug use in cardiac amyloid patients: insights from an international survey
Professor N. Mewton (Lyon, FR)
Abstract Slides Video
Presentation thumbnail
Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication, and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular EF) study
Professor J. Hulot (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey
Miss F. Guidetti (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Echocardiographic iron responders - assessing which HFrEF patients with iron deficiency benefit the most from iron therapy
Doctor C. Bakogiannis (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 2

The Event

Event poster

Heart Failure 2024

11 May 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Unlocking SGLT2 inhibitors: evaluating elderly HFrEF patients with and without T2DM
thumbnail
Congress Presentation
Dapagliflozin effect on cardiopulmonary function, reverse cardiac remodelling and biomarkers in a cohort of HFrEF patients
thumbnail
Congress Presentation
Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on mitochondrial-derived peptide-c and on markers of neurohumoral activation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources